Lyme Disease
The author of this report has been asked to offer a brief report about Lyme disease and some of the facts and issues surrounding the disease. First off, the author will research and discuss what has happened to the prospects of a Lyme disease vaccine. Second, the author will discuss why laboratory testing for Lyme disease is not yet definitive. Finally, the author will discuss what is generally done for the chronic and other effects of Lyme disease that lead patients to suffer. While there are options for dealing with Lyme disease, the disease has proved to be very vexing and troublesome.
As for what has happened with the Lyme disease vaccine, there actually was on in production but it was removed from the market in 2002. The vaccine was apparently at least somewhat effective but it was taken off the market in large part because there was insufficient consumer demand to justify keeping production intact. Further, the CDC asserts that anyone who received the vaccine prior to its discontinuation in 2002 is probably no longer protected from the disease given that the vaccine loses its efficacy over time not unlike a tetanus shot or other immunizations that have to re-done at certain intervals so as to uphold and maintain protection from the relevant disease (CDC, 2015).
As for laboratory testing and Lyme disease, the CDC heavily recommends doing a two-state lab test for the disease due to the amount of false positives and other results issues that can arise if the two-stage test is not done. The first step that is recommended by the CDC is what is known as the EIA test, which is short for enzyme immunoassay. Alternately, the first step can be what is known as the IFA, or indirect immunofluorescence assay. The former is much more commonly used than the latter. With this test, if the results come up negative, then no further tests are generally needed or recommended. If and only if the first test is positive, the testing physician should do what is known as the Western blot test. If the EIA or IFA is positive and the Western blot test is positive, then the patient almost certainly has Lyme disease. It is noted by the CDC that skipping the EIA or IFA is less than wise because the Western blot test can be positive but this does not mean the…
Sample Source(s) Used
References
CDC. (2015). Lyme disease vaccine -- Lyme Disease -- CDC. CDC.gov. Retrieved 27 September 2015, from http://www.cdc.gov/lyme/prev/vaccine.html
CDC. (2015). Two-step Laboratory Testing Process -- Lyme Disease -- CDC. CDC.gov. Retrieved 28 September 2015, from http://www.cdc.gov/lyme/diagnosistesting/labtest/twostep/index.html
Giorgi, A. (2015). Chronic (Persistent) Lyme Disease. Healthline. Retrieved 28 September 2015, from http://www.healthline.com/health/lyme-disease-chronic-persistent#Overview1
Related Documents
Study Document
Chronic Lyme Disease Lyme Disease Is a
Chronic Lyme Disease Lyme disease is a contentious illness, and the reality of chronic Lyme disease induced by unrelenting infection with the Lyme spirochete (Borrelia burgdorferi) is the topic of continued debate (Hogan 16). The objective of this paper is to analyze critically the claims of existence of the illness. The paper would also offer a discussion on why insurance companies should provide cover for patients suffering from the Lyme
Study Document
Lyme Disease Program Planning
Jefferson Township, a part of Morris Country, NJ has experienced a surging problem with a higher number of Lyme disease reported cases each year. Approximately 30,000 cases have been reported by the CDC. These growing number of cases has created worry as afflicted patients are looking to doctors and nurses to help with this potentially chronic and debilitating illness. With Lyme disease quickly becoming the most common vector-borne illness
Study Document
Methicillin Resistant Staphylococcus Aureus MRSA and Lyme Disease
Lyme Disease and Methicillin-Resistant Staphylococcus Aureus (MRSA)
Introduction
This text will concern itself with Lyme disease and methicillin-resistant staphylococcus aureus (MRSA). In so doing, it will not only give the description and epidemiology of the concerns, but also the etiology and prevention strategies. Further, diagnosis as well as treatment options and prognosis will be highlighted.
1. Lyme Disease
Description and Etiology
Described as an illness
Study Document
Lyme Disease and Rocky Mountain Spotted Fever
What the Tick? Tick Born Diseases in America
Introduction
Part predator, part parasite, the tick is considered by many as America’s most harmful bug. Living in humid and overgrown areas, these critters make rural America more prone to acquiring the various diseases these ticks carry. From Lyme disease to Rocky Mountain Spotted Fever, ticks are the proliferators of zoonotic diseases in North America (Edlow, 2004). These diseases do
Study Document
Lyme Disease Differential Diagnosis
Mr. Robinson is a 46-year-old man presenting with a four-day history of right ear pain. He described the pain as a constant, dull, burning pain radiating to the neck and face, associated with a feeling of congestion. The patient also stated that the right side of his face had felt numb for about one day. Three days earlier, Mr. Robinson was seen by PCP, who told him that his ear looked
Study Document
Disease Pathology Clinical Impression: Pertussis
However, since the patient is a 5-week-old male, he should be kept away from anyone who is coughing since they are at higher risk of life-threatening consequences. 3. What therapy would you suggest for this patient? Hospital admission is indicated for this patient since he is a 5-week-old infant and has not received the vaccine against pertussis. Recommended treatment by the 2005 CDC Guidelines include a 5-day course of azithromycin given